Leave a comment

CooperPhoto.2.2016Dr. Ziva Cooper
Department of Psychiatry
College of Physicians and Surgeons
Columbia University
1051 Riverside Drive Box 120
New York, NY 10032

Dr. Ziva Cooper is an Associate Professor of Clinical Neurobiology in the Department of Psychiatry at Columbia University Medical Center.  She focuses on preclinical and clinical studies on the behavioral and physiologic effects of psychoactive drugs that are of significant public health relevance, including cannabis and opioids. She received her PhD from the University of Michigan in Biopsychology in 2007 in the field of preclinical psychopharmacology.  Over the last ten years she has sought to translate preclinical studies of drug action to the clinic using controlled human laboratory studies to investigate the direct effects of abused substances.  Her current research, funded by NIDA and industry contracts, involves understanding the neurobiological, pharmacological, and behavioral variables that influence both the abuse liability and therapeutic potential of cannabinoids (cannabis, cannabinoid receptor agonists, and cannabidiol) and opioids. She served on the National Academies of Sciences Committee on the Health Effects of Marijuana that recently published a comprehensive consensus report of the health effects of cannabis and cannabinoids. Dr. Cooper also serves on editorial boards, is President of the International Study Group Investigating Drugs as Reinforcers (ISGIDAR), and is Associate Editor of The American Journal of Drug and Alcohol Abuse.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

ISGIDAR CPDD Meeting 2019

June 15th, 2019
88 days to go.


The mission of ISGIDAR is to promote interest in, and to facilitate the dissemination of, new information related to drugs as reinforcers, especially as it may relate to human drug abuse.
%d bloggers like this: